Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (131-140 of 418) with videos related to

Pageof 42
Sort By:
BMC Medicine|July 3, 2023
Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomesAlberto Servetto, Massimo Di Maio, Fabio Salomone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Survey of modalities of toxicity assessment and reporting in noncomparative prospective studies of chemotherapy in breast cancerFrancesco Perrone, Ermelinda De Maio, Paolo Maione, et al.
Current Pharmaceutical Design|November 7, 2013
Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better…Massimo Di Maio, Alessandro Morabito, Maria Carmela Piccirillo, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
The prognostic role of pre-chemotherapy hemoglobin level in patients with ovarian cancerMassimo Di Maio, Carmela Pisano, Rosa Tambaro, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 31, 2006
The impact of chemotherapy-induced nausea and vomiting on health-related quality of lifeEnzo Ballatori, Fausto Roila, Benedetta Ruggeri, et al.
Expert Opinion on Biological Therapy|January 7, 2014
New biological treatments for gynecological tumors: focus on angiogenesisGennaro Daniele, Massimo Di Maio, Maria Carmela Piccirillo, et al.
Expert Opinion on Investigational Drugs|November 5, 2010
New drugs in advanced non-small-cell lung cancer: searching for the correct clinical developmentMassimo Di Maio, Alessandro Morabito, Maria Carmela Piccirillo, et al.
International Journal of Clinical Oncology|September 29, 2017
MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progressionChiara Baratelli, Marco Tampellini, Massimo Di Maio, et al.
Future Oncology (London, England)|June 27, 2019
Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapyPaolo Bossi, Laura Botta, Paolo Bironzo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 2, 2011
Is flexible bronchoscopy necessary to confirm the position of double-lumen tubes before thoracic surgery?Mario de Bellis, Rosanna Accardo, Massimo Di Maio, et al.
Pageof 42

Showing results (131-140 of 418) with videos related to

Sort By:
Pageof 42
BMC Medicine|July 3, 2023
Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomesAlberto Servetto, Massimo Di Maio, Fabio Salomone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Survey of modalities of toxicity assessment and reporting in noncomparative prospective studies of chemotherapy in breast cancerFrancesco Perrone, Ermelinda De Maio, Paolo Maione, et al.
Current Pharmaceutical Design|November 7, 2013
Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better…Massimo Di Maio, Alessandro Morabito, Maria Carmela Piccirillo, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
The prognostic role of pre-chemotherapy hemoglobin level in patients with ovarian cancerMassimo Di Maio, Carmela Pisano, Rosa Tambaro, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 31, 2006
The impact of chemotherapy-induced nausea and vomiting on health-related quality of lifeEnzo Ballatori, Fausto Roila, Benedetta Ruggeri, et al.
Expert Opinion on Biological Therapy|January 7, 2014
New biological treatments for gynecological tumors: focus on angiogenesisGennaro Daniele, Massimo Di Maio, Maria Carmela Piccirillo, et al.
Expert Opinion on Investigational Drugs|November 5, 2010
New drugs in advanced non-small-cell lung cancer: searching for the correct clinical developmentMassimo Di Maio, Alessandro Morabito, Maria Carmela Piccirillo, et al.
International Journal of Clinical Oncology|September 29, 2017
MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progressionChiara Baratelli, Marco Tampellini, Massimo Di Maio, et al.
Future Oncology (London, England)|June 27, 2019
Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapyPaolo Bossi, Laura Botta, Paolo Bironzo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 2, 2011
Is flexible bronchoscopy necessary to confirm the position of double-lumen tubes before thoracic surgery?Mario de Bellis, Rosanna Accardo, Massimo Di Maio, et al.
Pageof 42